Method of reducing the risk of adverse cardiovascular (cv) events associated with the administration of pharmaceutical agents which favor cv events

摘要: Methods and compositions for reducing the risks of adverse cardiovascular (CV) events associated with administration pharmaceutical agents which induce or increase risk one more CV events, particularly non-steroidal anti-inflammatory drags (NSAIDs) especially cyclooxygenase-2 (COX-2) inhibitors, are disclosed. The methods involve comprising event-inducing agent additional events. In specific embodiments, is selected from group consisting hydroxymethylglutaryl-coenzyme A reductase inhibitors (statins), angiotensin converting enzyme (ACE) II receptor blockers (ARBs).